Home Newsfeeds Needham Maintains Buy on PhaseBio Pharmaceuticals, Lowers Price Target to $8

Needham Maintains Buy on PhaseBio Pharmaceuticals, Lowers Price Target to $8

Needham analyst Serge Belanger maintains PhaseBio Pharmaceuticals (NASDAQ:PHAS) with a Buy and lowers the price target from $10 to $8.

byBenzinga Newsdesk

August 15, 2022

1 minute read

Needham analyst Serge Belanger maintains PhaseBio Pharmaceuticals (NASDAQ:PHAS) with a Buy and lowers the price target from $10 to $8.

J B Hunt Transport Reports Downbeat Earnings, Joins ASML And Other Big Stocks Moving Lower In Wednesday’s Pre-Market Session

By Avi Kapoor

April 17, 8:07 AM

U.S. stock futures were higher this morning, with the Dow futures gaining over 100 points on Wednesday.

ASML

Duluth Holdings Q2 EPS $0.07 Misses $0.15 Estimate, Sales $141.50M Miss $156.21M Estimate

By Benzinga Newsdesk

September 1, 6:54 AM

Duluth Holdings (NASDAQ:DLTH) reported quarterly earnings of $0.07 per share which missed the analyst consensus estimate of $0.15 by 53.33 percent. This is a 74.07 percent decrease over earnings of $0.27 per share from

DLTH

Seacoast Banking Q4 EPS $0.56 Beats $0.15 Estimate, Sales $137.49M Beat $134.68M Estimate

By Happy Mohamed

January 27, 1:04 AM

Seacoast Banking (NASDAQ:SBCF) reported quarterly earnings of $0.56 per share which beat the analyst consensus estimate of $0.15 by 273.33 percent. This is a 9.68 percent decrease over earnings of $0.62 per share from

SBCF

Morgan Stanley Maintains Equal-Weight on Peloton Interactive, Lowers Price Target to $5

By Benzinga Newsdesk

November 4, 9:16 AM

Morgan Stanley analyst Lauren Schenk maintains Peloton Interactive (NASDAQ:PTON) with a Equal-Weight and lowers the price target from $8 to $5.

PTON

Needham Maintains Buy on PhaseBio Pharmaceuticals, Lowers Price Target to $8

Related Posts

J B Hunt Transport Reports Downbeat Earnings, Joins ASML And Other Big Stocks Moving Lower In Wednesday’s Pre-Market Session

Duluth Holdings Q2 EPS $0.07 Misses $0.15 Estimate, Sales $141.50M Miss $156.21M Estimate

Seacoast Banking Q4 EPS $0.56 Beats $0.15 Estimate, Sales $137.49M Beat $134.68M Estimate

Morgan Stanley Maintains Equal-Weight on Peloton Interactive, Lowers Price Target to $5